Quarterly Results

JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia
BSE902.60-10.1 (-1.11 %)
PREV CLOSE ( ) 912.70
OPEN PRICE ( ) 912.65
BID PRICE (QTY) 902.75 (76)
OFFER PRICE (QTY) 904.00 (5)
VOLUME 1526
TODAY'S LOW / HIGH ( )901.90 913.00
52 WK LOW / HIGH ( )823.7 1250
NSE904.10-8.9 (-0.97 %)
PREV CLOSE( ) 913.00
OPEN PRICE ( ) 909.90
BID PRICE (QTY) 903.15 (4)
OFFER PRICE (QTY) 903.90 (3)
VOLUME 58834
TODAY'S LOW / HIGH( ) 900.50 914.60
52 WK LOW / HIGH ( )802 1248
Quarters
Select year  
( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
21225
19664
19007
19288
Total Expenditure
18330
16250
16111
15834
PBIDT (Excl OI)
2895
3414
2896
3454
Other Income
205
98
120
119
Operating Profit
3100
3512
3016
3573
Interest
561
502
490
527
Exceptional Items
-397
-58
0.00
-33
PBDT
2142
2952
2526
3013
Depreciation
1207
1048
981
952
Profit Before Tax
935
1904
1545
2061
Tax
376
704
519
547
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
559
1200
1026
1514
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
559
1200
1026
1514
Minority Interest
1
4
4
23
Shares of Associates
-1
-1
-1
-1
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
559
1203
1029
1536
Equity Capital
158
158
158
158
Face Value (IN RS)
1
1
1
1
Reserves
NA
NA
NA
NA
Calculated EPS
3.53
7.61
6.51
9.72
Calculated EPS (Annualised)
14.15
30.45
26.05
38.88
No of Public Share Holdings
83342517
83342517
83342517
78564083
% of Public Share Holdings
52.32
52.32
52.32
49.32
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
13.63
17.36
15.23
17.90
PBIDTM%
14.60
17.86
15.86
18.52
PBDTM%
10.09
15.01
13.28
15.62
PBTM%
4.40
9.68
8.12
10.68
PATM%
2.63
6.10
5.39
7.84
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.